Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
Alpha Conducting solution product codes: 3310-25 ASCR - Product Usage: Recalled by Pharmaceutical Innovations, Inc. Due to Potential for failed stability antimicrobial effectiveness testing.
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Pharmaceutical Innovations, Inc. directly.
Affected Products
Alpha Conducting solution product codes: 3310-25 ASCR - Product Usage: Electrode Conductivity Spray Solution.
Quantity: N/A
Why Was This Recalled?
Potential for failed stability antimicrobial effectiveness testing.
Where Was This Sold?
This product was distributed nationwide across all 50 states.
About Pharmaceutical Innovations, Inc.
Pharmaceutical Innovations, Inc. has 6 total recalls tracked by RecallDetector.
Related Recalls
EndoVive Safety PEG Kit Recalled by Boston Scientific Corporation Due to Recall of kits which utilized ChloraPrep Triple Swabsticks...
Boston Scientific Corporation · February 10, 2026
Owner's Booklets and Instructions for Use that are used with Recalled by Trividia Health, Inc. Due to The system labeling (user manual and online labeling)...
Trividia Health, Inc. · February 6, 2026
Artelon FlexBand Dynamic Matrix Ref: 31057 Recalled by International Life Sciences Due to Augmentation devices failed bacterial endotoxin testing.
International Life Sciences · February 6, 2026
Owner's Booklets and Instructions for Use that are used with Recalled by Trividia Health, Inc. Due to The system labeling (user manual and online labeling)...
Trividia Health, Inc. · February 6, 2026
Owner's Booklets and Instructions for Use that are used with Recalled by Trividia Health, Inc. Due to The system labeling (user manual and online labeling)...
Trividia Health, Inc. · February 6, 2026
Data sourced from the FDA (Device). Last updated March 26, 2026. View original report